Long hours spent waiting during cancer treatment can be exhausting for patients and their families. To ease this burden, a group transformed the open waiting area at Lagos State University Teaching ...

On January 27, Citi analyst Geoff Meacham raised his price objective on Bristol-Myers Squibb Company (NYSE:BMY) to $60 from ...

Two new studies highlight the potential of fecal microbiota transplantation as a boon to cancer immunotherapy.

What's new in proton therapy? Read the latest news and views from Fred Hutch's proton therapy facility’s patients and providers in The Beam, published monthly.

The trial will include patients with pancreatic, colorectal, non-small cell lung, and other cancers that harbor KRAS G12V mutations.

In this analysis, the researchers used data from the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial to examine the link between alcohol intake and colorectal cancer.

The FDA accepted an application for ivonescimab with chemotherapy for patients with lung cancer driven by EGFR changes after ...

Our neighbors were selling their home and had it tested for radon. The test was positive. Why should we be concerned about ...

New England Patriots fan and neonatal intensive care nurse Shelly Sepulveda, RN, died at age 42 of ovarian cancer on Jan. 26, just 2 weeks after being gifted two Super Bowl tickets by Patriots owner ...

The FDA accepted the BLA for ivonescimab plus chemotherapy for patients with EGFR-mutated non-small cell lung cancer post-TKI ...

Ivonescimab's BLA acceptance is a milestone for PD-1/VEGF bispecific antibodies in the U.S., potentially transforming ...

The FDA is currently reviewing Summit's PD-1/VEGF bispecific as part of a chemotherapy combo for the treatment of locally advanced or metastatic non-squamous non-small cell lung cancer.